Metastatic thyroid cancer occurring as an unknown primary lesion - The role of F-18FDG positron emission tomography

Dede F., Ajoedi N., Ansari S., Jana S., Heiba S., Abdel-Dayem H.

CLINICAL NUCLEAR MEDICINE, cilt.26, sa.5, ss.396-399, 2001 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 26 Sayı: 5
  • Basım Tarihi: 2001
  • Doi Numarası: 10.1097/00003072-200105000-00004
  • Dergi Adı: CLINICAL NUCLEAR MEDICINE
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.396-399
  • Anahtar Kelimeler: F-18 fluorodeoxyglucose positron emission, tomography, metastatic thyroid cancer, unknown primary, PET
  • Marmara Üniversitesi Adresli: Hayır

Özet

Thyroid cancer can appear as metastatic disease of an unknown primary origin, and fluorine-18 fluorodeoxyglucose (F-18 FDG) positron emission tomographic (PET) studies are helpful in the workup evaluation of these patients, The authors describe two patients who had metastatic disease from an unknown primary lesion, F-18 FDG PET studies played an important role in localizing the primary malignant site in the thyroid gland, The utility of F-18 FDG imaging in decreasing the number of procedures, cost, and inconvenience to patients is shown clearly in both cases.